Moderna Inc (MRNA)
129.65
-0.07 -0.05%
NASDAQ
Jan 15, 20:00
USD
Moderna Market Cap:
51.30B for Jan. 15, 2021View 4,000+ financial data types
Browse...
View Full Chart
Market Cap Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Market Cap Data
View and export this data going back to 2018.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Jan. 15, 2021 | 51.30B |
| Jan. 14, 2021 | 51.33B |
| Jan. 13, 2021 | 49.09B |
| Jan. 12, 2021 | 49.29B |
| Jan. 11, 2021 | 46.40B |
| Jan. 8, 2021 | 44.62B |
| Jan. 7, 2021 | 45.54B |
| Jan. 6, 2021 | 46.01B |
| Jan. 5, 2021 | 43.20B |
| Jan. 4, 2021 | 44.21B |
| Dec. 31, 2020 | 41.34B |
| Dec. 30, 2020 | 43.98B |
| Dec. 29, 2020 | 45.27B |
| Dec. 28, 2020 | 44.08B |
| Dec. 24, 2020 | 48.83B |
| Dec. 23, 2020 | 51.58B |
| Dec. 22, 2020 | 49.81B |
| Dec. 21, 2020 | 54.73B |
| Dec. 18, 2020 | 55.49B |
| Dec. 17, 2020 | 56.98B |
| Dec. 16, 2020 | 54.22B |
| Dec. 15, 2020 | 58.26B |
| Dec. 14, 2020 | 61.36B |
| Dec. 11, 2020 | 62.10B |
| Dec. 10, 2020 | 61.61B |
| Dec. 9, 2020 | 61.96B |
| Dec. 8, 2020 | 67.22B |
| Dec. 7, 2020 | 63.12B |
| Dec. 4, 2020 | 60.35B |
| Dec. 3, 2020 | 62.23B |
| Dec. 2, 2020 | 56.59B |
| Dec. 1, 2020 | 55.80B |
| Nov. 30, 2020 | 60.44B |
| Nov. 27, 2020 | 50.27B |
| Nov. 25, 2020 | 43.20B |
| Nov. 24, 2020 | 39.00B |
| Nov. 23, 2020 | 39.98B |
| Nov. 20, 2020 | 38.63B |
| Nov. 19, 2020 | 36.71B |
| Nov. 18, 2020 | 35.17B |
| Nov. 17, 2020 | 36.86B |
| Nov. 16, 2020 | 38.76B |
| Nov. 13, 2020 | 35.37B |
| Nov. 12, 2020 | 34.75B |
| Nov. 11, 2020 | 32.62B |
| Nov. 10, 2020 | 30.09B |
| Nov. 9, 2020 | 30.76B |
| Nov. 6, 2020 | 28.67B |
| Nov. 5, 2020 | 28.29B |
| Nov. 4, 2020 | 27.62B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Advertisement
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Benchmarks
| Dynavax Technologies Corp | 565.19M |
| Regeneron Pharmaceuticals Inc | 55.27B |
| Gilead Sciences Inc | 79.39B |
Market Cap Range, Past 5 Years
| Minimum | 4.048B | Aug 05 2019 |
| Maximum | 67.22B | Dec 08 2020 |
| Average | 15.40B |
Market Cap Related Metrics
| PS Ratio | 192.18 |
| PEG Ratio | -130.54 |
| Price to Book Value | 18.59 |
| Price to Free Cash Flow | 77.36 |
| Price | 129.65 |
| Earnings Yield | -1.25% |
| PEGY Ratio | -130.54 |
News
EU nations say COVID vaccine rollout is slow with uncertain timetables -sources
Yahoo 01/15 06:11 ET
Yahoo 01/15 06:11 ET
Lonza awaits licence for Swiss plant making Moderna COVID-19 vaccine ingredients
Yahoo 01/14 05:40 ET
Yahoo 01/14 05:40 ET
Advertisement
